Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein 20A is a member of a small gene family found in a cluster on human chromosome 13q21.1, which includes several highly similar paralogs (PRR20B, PRR20C, PRR20D, PRR20E). The encoded protein is rich in proline residues and is typically 73–221 amino acids in length, identifying it as part of the proline-rich protein family. Despite the presence of several PRINTS domains and predicted dopamine D4 receptor signatures, there is currently no evidence that PRR20A functions as a receptor or other typical therapeutic target, and its precise biological role, disease associations, and drug interactions remain uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein 20A (PRR20A).